Abbott Laboratories ABT

101.29 0.22 0.22% as of 25 Sep
Market cap
$174.8B
P/E
32.8×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month

Abbott Laboratories (ABT) P/S ratio

As of 25 September 2026, Abbott Laboratories (ABT) trades at a P/S ratio of 3.8×. Over the past ten years it has ranged from 2.7× (February 2016) to 6.6× (February 2021); the current reading is higher than 29% of that period. That is above the Medical Devices industry median of 2.7× and in line with the Healthcare sector median of 3.8×.

P/S ratio, daily

Annual

Period P/S ratio Change
FY2025 4.9× 4.89%
FY2024 4.7× (1.55%)
FY2023 4.8× 8.29%
FY2022 4.4× (24.12%)
FY2021 5.8× 3.39%
FY2020 5.6× 16.53%
FY2019 4.8× 15.75%
FY2018 4.2× 11.34%
FY2017 3.7× 35.03%
FY2016 2.8× (16.00%)

Quarterly

Period P/S ratio Change
Jun 2026 3.4× (14.47%)
Mar 2026 4.0× (19.45%)
Dec 2025 4.9× (7.54%)
Sep 2025 5.3× (3.24%)
42 more quarters

Against its own ten years

Low 2.7× High 6.6×
Ten-year median 4.4×
Current reading's percentile 29

P/S ratio against peers

Company P/S ratio
PHG Koninklijke Philips N.V. compare 1.2×
GEHC GE HealthCare Technologies Inc. compare 1.4×
MDT Medtronic PLC compare 3.0×
BSX Boston Scientific Corporation compare 3.1×
STE STERIS plc compare 3.4×
ABT Abbott Laboratories 3.8×
SYK Stryker Corporation compare 4.0×
DXCM DexCom, Inc. compare 6.7×
EW Edwards Lifesciences Corporation compare 7.6×
Medical Devices industry median 2.7×
Healthcare sector median 3.8×
Market median 2.0×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on ABT